BioLine Rx Ltd (FRA:YP2)
€ 2.54 -0.72 (-22.09%) Market Cap: 11.05 Mil Enterprise Value: 7.49 Mil PE Ratio: 9,999.00 PB Ratio: 0.79 GF Score: 21/100

Half Year 2025 BioLine RX Ltd Earnings Call Transcript

Aug 14, 2025 / 12:30PM GMT
Release Date Price: €2.98
Operator

Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx second-quarter 2025 financial results conference call. (Operator Instructions)

I would now like to turn over the call to Irina Koffler, Investor Relations. Irina, please go ahead.

Irina Koffler
BioLine RX Ltd - Head of Investor Relations & Corporate Communications

Thank you, operator, and welcome, everyone. Thank you for joining us on our quarterly results conference call. Earlier today, we issued a press release, a copy of which is available in the Investor Relations section of our website. It was also filed as a 6-K.

I'd like to remind you that certain statements we make during the call will be forward-looking. Because such statements deal with future events and are subject to many risks and uncertainties, actual results may differ materially from those in the forward-looking statements.

For a full discussion of these risks and uncertainties, please review our annual report on Form 20-F and our quarterly reports on Form 6-K that are filed with the US

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot